New pill targets rare, Hard-to-Treat cancers
NCT ID NCT03600233
Summary
This study is testing an experimental oral drug called CVM-1118 for people with advanced neuroendocrine tumors that have stopped responding to standard treatments. The main goal is to see if the drug can slow or stop the cancer from growing. Researchers will also closely monitor the drug's safety and how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang Gung Memorial Hospital, KaoHsiung
Kaohsiung City, Taiwan
-
Chang Gung Memorial Hospital, LinKou
Taoyuan, Taiwan
-
China Medical University Hospital
Taichung, Taiwan
-
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
New Taipei Municipal TuCheng Hospital
New Taipei City, Taiwan
-
Taichung Veterans General Hospital
Taichung, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.